Healthcare Services

A significant industry trend in the Tumor Profiling Market includes the Artificial Intelligence (AI)-Powered Diagnostic Innovations Driving Growth In The Market Through Enhanced Precision And Efficiency

April 7, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Will Be The Estimated Market Valuation Of The Tumor Profiling Market By The End Of 2030?

The tumor profiling market has seen rapid expansion in recent years. Its value is projected to rise from $11.18 billion in 2025 to $12.31 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.1%. Historically, this market’s expansion has been fueled by factors such as increasing cancer rates, the proliferation of molecular diagnostics laboratories, the growing adoption of targeted cancer therapies, continuous advancements in sequencing technologies, and an increase in oncology research funding.

The tumor profiling market is projected to experience robust expansion over the coming years. This market is anticipated to reach a valuation of $17.96 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.9%. The upward trajectory during the projected period stems from factors such as the increasing embrace of precision oncology, a rising need for individualized cancer therapies, developments in bioinformatics platforms, the broadening scope of companion diagnostics, and increased funding in translational cancer research. Key developments expected during this forecast span encompass wider adoption of next-generation sequencing, the escalating application of multi-omics profiling methods, greater incorporation of AI-powered data analysis, the broadening of personalized oncology uses, and a sharper emphasis on identifying biomarkers.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24420&type=smp

Which Market Drivers Are Supporting The Expansion Of The Tumor Profiling Market?

The increasing need for personalized medical approaches is anticipated to propel the expansion of the tumor profiling market in the future. Personalized medicine involves customizing healthcare interventions to align with the unique attributes of each patient. This heightened demand stems from patients’ desire for more accurate treatments that yield superior results and fewer adverse effects than conventional methods. Tumor profiling assists personalized medicine by detecting particular genetic mutations and biomarkers within a patient’s tumor, thereby facilitating precise treatments and minimizing side effects. As an illustration, in February 2024, a report from the Personalized Medicine Coalition, a US-based organization committed to advancing personalized medicine, indicated that personalized medicines constituted over one-third of all new drug approvals in 2023, continuing this pattern for the fourth consecutive year. Consequently, the rising demand for personalized medicine is fueling growth within the tumor profiling market.

Which Segment Classifications Shape The Tumor Profiling Market?

The tumor profiling market covered in this report is segmented –

1) By Technique: Genomics, Proteomics, Epigenetics, Metabolomics

2) By Technology: Sequencing Techniques, Quantitative Polymerase Chain Reaction (qPCR), Immunohistochemistry, In Situ Hybridization (ISH), Microarray

3) By Application: Personalized Cancer Medicine, Oncological Diagnostics, Research

Subsegments:

1) By Genomics: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Microarrays, Sanger sequencing

2) By Proteomics: Mass Spectrometry (MS), Protein Microarrays, Immunohistochemistry (IHC), Western Blotting

3) By Epigenetics: DNA Methylation Analysis, Chromatin Immunoprecipitation Sequencing (ChIP-seq), Histone Modification Profiling, Non-Coding RNA Analysis

4) By Metabolomics: Nuclear Magnetic Resonance (NMR) Spectroscopy, Gas Chromatography-Mass Spectrometry (GC-MS), Liquid Chromatography-Mass Spectrometry (LC-MS), Capillary Electrophoresis-Mass Spectrometry (CE-MS)

Which Trends Are Impacting The Growth Of The Tumor Profiling Market?

Major companies within the tumor profiling market are concentrating on developing sophisticated solutions, including those powered by artificial intelligence (AI) for diagnostics, to improve the accuracy and efficiency of cancer treatment. Artificial intelligence (AI) employs advanced computational methods for analyzing complex genomic, proteomic, and clinical data, thereby enabling faster diagnoses, the formulation of personalized treatment strategies, and more effective monitoring of disease progression. For instance, in January 2025, Panakeia Technologies LTD, a UK-based firm specializing in AI-driven software for cancer diagnosis and treatment, unveiled PANProfiler Colon. This AI-driven software solution is specifically designed to profile key molecular biomarkers, such as microsatellite instability (MSI) and mismatch repair deficiency (dMMR), directly from H and E-stained images of colon cancer tissue samples. This digital tool facilitates rapid and accurate molecular profiling of tumors, which is crucial for diagnosing colorectal cancer, identifying instances of Lynch syndrome, and informing personalized treatment decisions.

Which Companies Are Expanding Their Footprint In The Tumor Profiling Market?

Major companies operating in the tumor profiling market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Agilent Technologies Inc., Hologic Inc., Illumina Inc., Sysmex Corporation, QIAGEN N.V., Exact Sciences Corporation, Guardant Health Inc., GenScript Biotech Corporation, NeoGenomics Inc., Caris Life Sciences Inc., Tempus Inc., Foundation Medicine Inc., NanoString Technologies Inc., Personalis Inc., Boreal Genomics Inc., Strand Life Sciences Pvt. Ltd., HTG Molecular Diagnostics Inc., Lucence Health Inc., Predictive Oncology Inc.

Read the full tumor profiling market report here:

https://www.thebusinessresearchcompany.com/report/tumor-profiling-global-market-report

How Is The Tumor Profiling Market Distributed Across Key Geographic Regions?

North America was the largest region in the tumor profiling market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tumor profiling market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Tumor Profiling Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24420&type=smp

Browse Through More Reports Similar to the Global Tumor Profiling Market 2026, By The Business Research Company

Cancer Profiling Global Market Report

https://www.thebusinessresearchcompany.com/report/cancer-profiling-global-market-report

Cancer Diagnostics Global Market Report

https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report

Cancer Biomarker Global Market Report

https://www.thebusinessresearchcompany.com/report/cancer-biomarker-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795